Literature DB >> 17667736

The application of exposure therapy and D-cycloserine to the treatment of anorexia nervosa: a preliminary trial.

Joanna Steinglass1, Robyn Sysko, Janet Schebendach, Allegra Broft, Michael Strober, B Timothy Walsh.   

Abstract

OBJECTIVE: Novel approaches to the treatment of anorexia nervosa (AN) are needed. This preliminary study examined the utility and safety of an exposure therapy intervention and D-cycloserine (DCS) in a population of patients with AN.
METHOD: Eleven participants completed a series of 6 laboratory meals, including pre- and post-exposure test meals and four exposure sessions. Participants were randomly assigned to receive either DCS or placebo in double-blind fashion before each of the 4 exposure sessions. These results were compared to data from a previously studied group of patients who received treatment as usual.
RESULTS: Total caloric intake increased significantly from the baseline meal session to the post-test meal session in the patients who received the exposure therapy intervention. Caloric intake did not increase significantly in the comparison group.
CONCLUSION: These data suggest that an exposure therapy intervention specifically focused on meal consumption may be helpful in increasing intake of a test meal.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17667736      PMCID: PMC3638255          DOI: 10.1097/01.pra.0000281484.89075.a8

Source DB:  PubMed          Journal:  J Psychiatr Pract        ISSN: 1527-4160            Impact factor:   1.325


  24 in total

1.  Eating disorders and antecedent anxiety disorders: a controlled study.

Authors:  C M Bulik; P F Sullivan; J L Fear; P R Joyce
Journal:  Acta Psychiatr Scand       Date:  1997-08       Impact factor: 6.392

2.  Pathologic fear conditioning and anorexia nervosa: on the search for novel paradigms.

Authors:  Michael Strober
Journal:  Int J Eat Disord       Date:  2004-05       Impact factor: 4.861

3.  Influence of social norms and palatability on amount consumed and food choice.

Authors:  Patricia Pliner; Nikki Mann
Journal:  Appetite       Date:  2004-04       Impact factor: 3.868

4.  An inventory for measuring clinical anxiety: psychometric properties.

Authors:  A T Beck; N Epstein; G Brown; R A Steer
Journal:  J Consult Clin Psychol       Date:  1988-12

5.  Mortality in anorexia nervosa.

Authors:  P F Sullivan
Journal:  Am J Psychiatry       Date:  1995-07       Impact factor: 18.112

6.  The developmental association between eating disorders symptoms and symptoms of depression and anxiety in juvenile twin girls.

Authors:  Judy L Silberg; Cynthia M Bulik
Journal:  J Child Psychol Psychiatry       Date:  2005-12       Impact factor: 8.982

7.  Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats.

Authors:  David L Walker; Kerry J Ressler; Kwok-Tung Lu; Michael Davis
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

8.  Temporal patterns of hunger and fullness ratings and related cognitions in anorexia and bulimia.

Authors:  K A Halmi; S R Sunday
Journal:  Appetite       Date:  1991-06       Impact factor: 3.868

9.  A critical examination of the amenorrhea and weight criteria for diagnosing anorexia nervosa.

Authors:  T L Watson; A E Andersen
Journal:  Acta Psychiatr Scand       Date:  2003-09       Impact factor: 6.392

10.  Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.

Authors:  Stefan G Hofmann; Alicia E Meuret; Jasper A J Smits; Naomi M Simon; Mark H Pollack; Katherine Eisenmenger; Michael Shiekh; Michael W Otto
Journal:  Arch Gen Psychiatry       Date:  2006-03
View more
  15 in total

1.  Fear of food as a treatment target: exposure and response prevention for anorexia nervosa in an open series.

Authors:  Joanna Steinglass; Anne Marie Albano; H Blair Simpson; Kenneth Carpenter; Janet Schebendach; Evelyn Attia
Journal:  Int J Eat Disord       Date:  2011-05-03       Impact factor: 4.861

Review 2.  The Role of Psychotropic Medications in the Management of Anorexia Nervosa: Rationale, Evidence and Future Prospects.

Authors:  Guido K W Frank; Megan E Shott
Journal:  CNS Drugs       Date:  2016-05       Impact factor: 5.749

3.  Emotion and eating disorder symptoms in patients with anorexia nervosa: an experimental study.

Authors:  Jennifer E Wildes; Marsha D Marcus; Ashley C Bright; Marcela Marin Dapelo; Magister Clin Psychol
Journal:  Int J Eat Disord       Date:  2012-03-31       Impact factor: 4.861

Review 4.  Pharmacotherapy of eating disorders.

Authors:  Haley Davis; Evelyn Attia
Journal:  Curr Opin Psychiatry       Date:  2017-11       Impact factor: 4.741

5.  Diagnostic, clinical, and personality correlates of food anxiety during a food exposure in patients diagnosed with an eating disorder.

Authors:  Cheri A Levinson; Margarita Sala; Stuart Murray; Jackie Ma; Thomas L Rodebaugh; Eric J Lenze
Journal:  Eat Weight Disord       Date:  2019-03-07       Impact factor: 4.652

6.  Pre-meal anxiety and food intake in anorexia nervosa.

Authors:  Joanna E Steinglass; Robyn Sysko; Laurel Mayer; Laura A Berner; Janet Schebendach; Yuanjia Wang; Huaihou Chen; Anne Marie Albano; H Blair Simpson; B Timothy Walsh
Journal:  Appetite       Date:  2010-06-04       Impact factor: 3.868

7.  D-Cycloserine facilitation of exposure therapy improves weight regain in patients with anorexia nervosa: a pilot randomized controlled trial.

Authors:  Cheri A Levinson; Thomas L Rodebaugh; Laura Fewell; Andrea E Kass; Elizabeth N Riley; Lynn Stark; Kimberly McCallum; Eric J Lenze
Journal:  J Clin Psychiatry       Date:  2015-06       Impact factor: 4.384

Review 8.  Rationale for the application of exposure and response prevention to the treatment of anorexia nervosa.

Authors:  Joanna E Steinglass; Robyn Sysko; Deborah Glasofer; Anne Marie Albano; H Blair Simpson; B Timothy Walsh
Journal:  Int J Eat Disord       Date:  2011-03       Impact factor: 4.861

Review 9.  Glutamate receptors in extinction and extinction-based therapies for psychiatric illness.

Authors:  Karyn M Myers; William A Carlezon; Michael Davis
Journal:  Neuropsychopharmacology       Date:  2010-07-14       Impact factor: 7.853

10.  Caloric restriction enhances fear extinction learning in mice.

Authors:  Megan C Riddle; Morgan C McKenna; Yone J Yoon; Siobhan S Pattwell; Patricia Mae G Santos; B J Casey; Charles E Glatt
Journal:  Neuropsychopharmacology       Date:  2013-01-03       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.